ArticleInternational urology and nephrology2025
Machine learning and transcriptomic analysis identify tubular injury biomarkers in patients with chronic kidney disease.
Article in International urology and nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Machine learning and transcriptomics in the research on biomarkers of chronic kidney disease: technical robustness, clinical feasibility and ethical standards.International urology and nephrology · 2026Article
- Cross-Cohort Transcriptomic Integration Identifies IFIT2 as a Translational Diagnostic Biomarker and Functional Driver of Inflammation-Linked Tubular Injury in Chronic Kidney Disease.Human mutation · 2026Article
- Enhanced early chronic kidney disease prediction using hybrid waterwheel plant algorithm for deep neural network optimization.Scientific reports · 2025Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
Abstract
purposeChronic Kidney Disease (CKD) is emerging as a major public health problem, with a lack of precise diagnostic biomarkers in clinical settings. The primary objective is to discover biomarkers for early clinical detection of CKD and to gain a deeper understanding of its underlying pathophysiological processes.
methodsSamples from renal tubules of CKD patients and healthy controls were subjected to differential expression analysis. Weighted Gene Co-expression Network Analysis (WGCNA) was utilized to detect genes associated with renal tubular damage in CKD. Subsequently, Support Vector Machine Recursive Feature Elimination (SVM-RFE) and Least Absolute Shrinkage and Selection Operator (LASSO) algorithms were employed to identify and validate potential biomarker candidates.
resultsFour key renal biomarkers, namely DUSP1, GADD45A, TSC22D3, and ZFAND5, were successfully identified. Receiver Operating Characteristic (ROC) curve analysis and nomogram construction demonstrated their remarkable diagnostic capabilities. These biomarkers were also found to affect the degree of immune cell infiltration in CKD and exhibited a notable correlation with Glomerular Filtration Rate (GFR) and serum creatinine (SCr) levels.
conclusionThese four identified biomarkers for renal tubular injury play important roles in immune function and inflammatory responses in CKD, potentially providing a theoretical foundation for dissecting molecular mechanisms and developing therapeutic strategies in CKD.
Indexed as
Identifiers
40588704What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.